Catalyst Capital portfolio Therapure Biopharma proposes IPO

Catalyst Capital portfolio Therapure Biopharma proposes IPO
November 27
16:16 2015

Biopharmaceutical company Therapure Biopharma Inc. has filed a preliminary prospectus with securities regulatory authorities in each of the provinces and territories of Canada in connection with a proposed initial public offering of its common shares.

Therapure is a portfolio company of Catalyst Capital Group focused on manufacturing complex biologics for its customers and the development, manufacture and sale of its own blood and plasma-related therapeutic products.

The offering is being made through a syndicate of underwriters co-led by GMP Securities L.P., CIBC World Markets Inc. and National Bank Financial Inc.

Press release.

Related Articles

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter